Last Member Drive of 2025!

Your year-end tax-deductible gift powers our local newsroom. Help raise $1 million in essential funding for LAist by December 31.
$881,541 of $1,000,000 goal
A row of graphics payment types: Visa, MasterCard, Apple Pay and PayPal, and  below a lock with Secure Payment text to the right
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen

This is an archival story that predates current editorial management.

This archival content was written, edited, and published prior to LAist's acquisition by its current owner, Southern California Public Radio ("SCPR"). Content, such as language choice and subject matter, in archival articles therefore may not align with SCPR's current editorial standards. To learn more about those standards and why we make this distinction, please click here.

News

Oh Nuts! Propecia Masks Prostate Cancer Tests

Truth matters. Community matters. Your support makes both possible. LAist is one of the few places where news remains independent and free from political and corporate influence. Stand up for truth and for LAist. Make your year-end tax-deductible gift now.

A recent study has shown that the popular hair-loss drug Propecia can cockblock tests for prostate cancer.

In findings that were ironically funded by pharmaceutical giant Merck, the maker of Propecia, the drug that in some cases, can limit the natural disappearance of hair, can also limit the reliability of the commonly used prostate-specific antigen (PSA) test.

Men using Propecia "should be aware that their PSA will be falsely lowered" and that small changes upward could be signs of trouble, said study lead author Dr. Anthony D'Amico, chief of genitourinary radiation oncology at Brigham and Women's Hospital in Boston. - HealthDay News

Apparently 40% of the men studied between 40-49 had their PSA levels lowered after less than a year of taking Propecia, and 50% of men between 50-59 had lower PSAs. Meanwhile those men who took the placebo found their PSA rise on average of 13%.photo by Britt Elizabeth

You come to LAist because you want independent reporting and trustworthy local information. Our newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our connected community. We are free to tell the full truth, to hold power to account without fear or favor, and to follow facts wherever they lead. Our only loyalty is to our audiences and our mission: to inform, engage, and strengthen our community.

Right now, LAist has lost $1.7M in annual funding due to Congress clawing back money already approved. The support we receive before year-end will determine how fully our newsroom can continue informing, serving, and strengthening Southern California.

If this story helped you today, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.

Your tax-deductible donation keeps LAist independent and accessible to everyone.
Senior Vice President News, Editor in Chief

Make your tax-deductible year-end gift today

A row of graphics payment types: Visa, MasterCard, Apple Pay and PayPal, and  below a lock with Secure Payment text to the right